Petersson Lena-Marie, Vaez Marjan, Nilsson Marie I, Saboonchi Fredrik, Alexanderson Kristina, Olsson Mariann, Wennman-Larsen Agneta
Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Division of Nursing, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Scand J Caring Sci. 2018 Jun;32(2):715-724. doi: 10.1111/scs.12502. Epub 2017 Oct 19.
Most women of working ages with limited breast cancer (BC) have returned to work within the first year after diagnosis. However, little is known about what is happening during this year regarding sickness absence and return to work. Also, the knowledge is very limited about the occurrence of part-time sickness absence after BC diagnosis. Therefore, the aim of this study was to describe occurrence, extent and length of SA during a two-year follow-up after BC surgery and to analyse the association between being SA and type of cancer treatment.
In this prospective cohort study, 497 women responded to questionnaires about different aspects of sickness absence at six occasions during two years after primary BC surgery (at baseline and after 4, 8, 12, 18 and 24 months). Treatment information was obtained from the National breast cancer register. Multinomial logistic regression was used to calculate odds ratios (OR) for likelihood of being sickness absent more than once.
Two-thirds of the women were sickness absent at baseline; this proportion decreased, especially during the first eight months. At 24 months, 13% were sickness absent. Of all women, 27% never reported sickness absence and 14% were sickness absent at most of the six survey times. At eight months, many had shifted from full- to part-time sickness absence. Women with chemotherapy and/or advanced BC surgery had higher ORs for being sickness absent at most of the follow-ups.
Most women returned to work within the first eight months after BC surgery and of those sickness absent after that, most had been part-time sickness absent. Thus, it is important to differentiate between part- and full-time sickness absence in future studies. Special attention should be paid to the impact of chemotherapy and type of surgery on the likelihood of being sickness absent.
大多数患有早期乳腺癌的职业女性在确诊后的第一年内就重返工作岗位。然而，对于这一年中病假情况以及重返工作岗位的情况却知之甚少。此外，关于乳腺癌诊断后兼职病假的发生情况，了解也非常有限。因此，本研究的目的是描述乳腺癌手术后两年随访期间病假的发生情况、程度和时长，并分析病假与癌症治疗类型之间的关联。
在这项前瞻性队列研究中，497名女性在原发性乳腺癌手术后的两年内（基线时以及术后4、8、12、18和24个月）六次回答了关于病假不同方面的问卷。治疗信息从国家乳腺癌登记处获取。采用多项逻辑回归计算多次病假可能性的比值比（OR）。
三分之二的女性在基线时请了病假；这一比例有所下降，尤其是在最初的八个月。到24个月时，13%的女性请了病假。在所有女性中，27%从未报告过病假，14%在六次调查中的大部分时间都请了病假。在八个月时，许多人从全时病假转为兼职病假。接受化疗和/或进行晚期乳腺癌手术的女性在大多数随访中请病假的OR值更高。
大多数女性在乳腺癌手术后的前八个月内重返工作岗位，在那之后请病假的女性中，大多数是兼职病假。因此，在未来的研究中区分兼职病假和全时病假很重要。应特别关注化疗和手术类型对病假可能性的影响。
